| ||Audit Committee||Compensation & Stock Option Committee||Corporate Governance & Nominating Committee||Strategic Transactions Committee|
|Eric H. Bjerkholt
|Eric H. Bjerkholt|
Senior Vice President and CFO, Sunesis Pharmaceuticals, Inc.
Eric Bjerkholt was elected to the Board of Directors of StemCells, Inc. in March 2004. He is Senior Vice President
and Chief Financial Officer of Sunesis Pharmaceuticals, Inc., a small molecule biopharmaceutical company in South
San Francisco, California. Before joining Sunesis, Mr. Bjerkholt served as the Senior Vice President and Chief
Financial Officer of IntraBiotics Pharmaceuticals, Inc. Previously, Mr. Bjerkholt co-founded LifeSpring Nutrition,
Inc., a privately held ...
|Ricardo B. Levy, PhD |
|Ricardo B. Levy, PhD|
Retired Founder, Chairman & CEO, Catalytica, Inc.
Ricardo Levy was elected to the Board of Directors of StemCells, Inc. in September 2001. He most recently served as Lead Director of Renegy Holdings, the successor of Catalytica Energy Systems, Inc., an environmental emissions solutions provider. Prior to his role with Renegy Holdings, Dr. Levy served as Chairman of the Board of Catalytica Energy Systems from 1995, when the company was formed as a subsidiary of Catalytica, Inc., until October 2007 when the company merged to form Renegy....
|John J. Schwartz, PhD |
|John J. Schwartz, PhD|
Chairman of the Board
President, Quantum Strategies Management
John Schwartz was elected to the Board of Directors of StemCells, Inc. in December 1998 and was elected
the Chairman of the Board at the same time. He is the former President and Chief Executive Officer of SyStemix, Inc.
Dr. Schwartz is currently the President of Quantum Strategies Management Company, a registered investment
advisor located in Palo Alto, California. Prior to his positions at SyStemix, he served as Assistant Professor, Vice
President and General Counsel at S...